Investigating the Effect of Obicetrapib on Lipoprotein Metabolism

NCT05972278 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Lipid Metabolism

Interventions

DRUG: Obicetrapib

Sponsor

NewAmsterdam Pharma

Collaborators

[object Object]